Get startedLog in
    Picture of Avadel Pharmaceuticals logo

    AVDL — Avadel Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapHigh Flyer
    All News

    Brief: Avadel Pharmaceuticals Strengthens Sleep Medicine Portfolio With Exclusive License Of Valiloxybate From XWPharma Ltd

    Picture of Avadel Pharmaceuticals logoAvadel Pharmaceuticals
    03/09/2025 22:51
    Sept 3 (Reuters) - Avadel Pharmaceuticals PLC AVDL.O:

AVADEL PHARMACEUTICALS STRENGTHENS SLEEP MEDICINE PORTFOLIO WITH EXCLUSIVE LICENSE OF VALILOXYBATE FROM XWPHARMA LTD

AVADEL PHARMACEUTICALS PLC - XWPHARMA TO RECEIVE $20 MILLION UPFRONT AND $30 MILLION IN MILESTONES

AVADEL PHARMACEUTICALS PLC - TO PAY XWPHARMA UP TO $155 MILLION IN SALES MILESTONES

AVADEL PHARMACEUTICALS PLC - PLANS INITIAL PK STUDY FOR VALILOXYBATE IN Q4 2025

AVADEL PHARMACEUTICALS PLC - TO PAY TIERED ROYALTIES FROM HIGH-SINGLE DIGIT TO MID-TEENS

Source text: ID:nGNX2gV0V0

Further company coverage: AVDL.O

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Avadel Pharmaceuticals

    See all news